AirSculpt Technologies (NASDAQ:AIRS) Shares Down 1.3% – Should You Sell?

Shares of AirSculpt Technologies, Inc. (NASDAQ:AIRS) fell 1.3% on Friday . The stock traded as low as $4.55 and last traded at $4.61. Approximately 266,424 shares changed hands during mid-day trading, a decline of 38% from the average session volume of 431,765 shares. The stock had previously closed at $4.67.

Analyst Upgrades and Downgrades

Several research firms have issued reports on AIRS. Weiss Ratings raised shares of AirSculpt Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 1st. Leerink Partners set a $4.50 price objective on shares of AirSculpt Technologies in a research note on Thursday, May 14th. Finally, Wall Street Zen upgraded shares of AirSculpt Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $4.50.

AirSculpt Technologies Price Performance

The company has a 50 day moving average of $4.83 and a 200 day moving average of $3.37. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $325.24 million, a price-to-earnings ratio of -27.12 and a beta of 2.34.

AirSculpt Technologies (NASDAQ:AIRS) last posted its quarterly earnings data on Friday, May 8th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01). AirSculpt Technologies had a negative net margin of 7.39% and a negative return on equity of 4.98%. The company had revenue of $39.39 million for the quarter, compared to analyst estimates of $39.20 million.

Hedge Funds Weigh In On AirSculpt Technologies

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Balyasny Asset Management L.P. increased its position in AirSculpt Technologies by 128.5% during the second quarter. Balyasny Asset Management L.P. now owns 1,113,843 shares of the company’s stock worth $5,380,000 after purchasing an additional 626,309 shares during the last quarter. Renaissance Technologies LLC acquired a new position in shares of AirSculpt Technologies in the 4th quarter valued at $1,991,000. Vanguard Group Inc. grew its stake in shares of AirSculpt Technologies by 10.8% during the 3rd quarter. Vanguard Group Inc. now owns 782,543 shares of the company’s stock valued at $6,276,000 after buying an additional 76,291 shares during the period. Geode Capital Management LLC grew its stake in shares of AirSculpt Technologies by 4.6% during the 4th quarter. Geode Capital Management LLC now owns 403,163 shares of the company’s stock valued at $798,000 after buying an additional 17,889 shares during the period. Finally, Saba Capital Management L.P. acquired a new stake in shares of AirSculpt Technologies during the 4th quarter worth $620,000. Institutional investors and hedge funds own 91.54% of the company’s stock.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.